Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
Renske Wever
SkylineDx BV
Learn more about SSRN Profiles
SCHOLARLY PAPERS
1
DOWNLOADS
55
TOTAL CITATIONS
0
Feedback
Scholarly Papers (1)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
Identification of Stage I and II Melanoma Patients at High Risk for Recurrence Using a Model Combining Clinicopathologic Factors with Gene Expression Profiling (CP-GEP)
Number of pages: 19
Posted: 30 Nov 2022
Teresa Amaral
,
Tobias Sinnberg
,
Eftychia Chatziioannou
,
Heike Niessner
,
Ulrike Leiter
,
Ulrike Keim
,
Andrea Forschner
,
Jvalini Dwarkasing
,
Félicia Tjien-Fooh
, Renske Wever,
Lukas Flatz
,
Alexander M.M. Eggermont
and
Stephan Forchhammer
University of Tübingen - Centre for Dermatooncology, University of Tübingen, University of Tübingen, University of Tübingen, University of Tübingen, University of Tübingen, University of Tübingen, SkylineDx BV, SkylineDx BV, SkylineDx BV, University of Tübingen, Princess Máxima Center for Pediatric Oncology and University of Tübingen
Downloads
55
(1,010,164)
View PDF
Download
Abstract:
early stage melanoma, CP-GEP, biomarkers, adjuvant therapy, risk stratification
Feedback
